The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Effervescent Cold Relief
Aspirin, Chlorpheniramine Maleate, Phylephrine Bitartrate · PHENYLEPHRINE BITARTRATE 7.8 mg/1; ASPIRIN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1 · Tablet, Effervescent · Oral · Topco Associates LLC
NDC 36800-0768-20 · 10 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Aspirin, Chlorpheniramine Maleate, Phylephrine Bitartrate (Tablet, Effervescent)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Dolgencorp, Llc | ASPIRIN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE BITARTRATE 7.8 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Topco Associates LLC | PHENYLEPHRINE BITARTRATE 7.8 mg/1; ASPIRIN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Topco Associates LLC | PHENYLEPHRINE BITARTRATE 325 mg/1; ASPIRIN 2 mg/1; CHLORPHENIRAMINE MALEATE 7.8 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Topco Associates LLC | ASPIRIN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE BITARTRATE 7.8 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Effervescent Cold Relief — NDC 36800-0768-20," retrieved September 3, 2026, https://drugdashboards.com/drug/36800076820.
Free to cite with attribution — see how the data is put together.